Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2017
09 Gennaio 2018 - 06:00PM
Disclosure of
Share Capital and Voting Rights Outstanding as of December 31,
2017
(Pursuant to Article L.233-8 II of
the French Commercial Code
and articles 221-1 and 223-16 of the General Regulations of the
Autorité des Marchés Financiers)
Charenton-le-Pont, France (January 9, 2018 - 6.00 p.m.)
- As of December 31, 2017, shares and voting rights outstanding of
Essilor, the world leader in ophthalmic optics, broke down as
follows:
|
December 31, 2017 |
Shares
outstanding |
219,125,439 |
Exercisable
voting rights |
234,699,753 |
Total
voting rights, based on all outstanding shares,
including shares stripped of their voting rights* |
236,044,180 |
(*) Shares held
by the Company.
About Essilor
Essilor International (Compagnie Générale
d'Optique) ("Essilor") is the world's leading ophthalmic optics
company. Essilor designs, manufactures and markets a wide range of
lenses to improve and protect eyesight. Its mission is to improve
lives by improving sight. To support this mission, Essilor
allocates more than €200 million to research and innovation every
year, in a commitment to continuously bring new, more effective
products to market. Its flagship brands are Varilux®,
Crizal®,
Transitions®,
EyezenTM,
Xperio®, Foster
Grant®,
BolonTM and
Costa®. It also
develops and markets equipment, instruments and services for
eyecare professionals.
Essilor reported consolidated revenue of more than
€7.1 billion in 2016 and employs approximately 64,000 people
worldwide. It markets its products in more than 100 countries and
has 33 plants, 490 prescription laboratories and edging facilities,
as well as 5 research and development centers around the world (as
of December 31, 2016). For more information, please visit
www.essilor.com.
The Essilor International share trades on the
Euronext Paris market and is included in the Euro Stoxx 50 and CAC
40 indices.
Codes and symbols: ISIN: FR0000121667; Reuters:
ESSI.PA; Bloomberg: EI:FP.
------------------------
Investor Relations
and Financial Communications
Phone: +33 (0)1 49 77 42 16
PDF Version of the news
release
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Essilor International via Globenewswire